×
About 21,104 results

ALLMedicine™ Parkinson Disease Center

Research & Reviews  10,103 results

Should we start integrating genetic data in decision-making on device-aided therapies i...
https://doi.org/10.1016/j.parkreldis.2021.05.013
Parkinsonism & Related Disorders; Salles PA, Mata IF et. al.

Jun 13th, 2021 - Parkinson disease (PD) is a complex heterogeneous neurodegenerative disorder. Association studies have revealed numerous genetic risk loci and variants, and about 5-10% suffer from a monogenic form. Because the presentation and course of PD is uni...

RNA-sequencing of peripheral blood circular RNAs in Parkinson disease.
https://doi.org/10.1097/MD.0000000000025888
Medicine Kong F, Lv Z et. al.

Jun 11th, 2021 - Circular RNAs (circRNAs) play an important role in many neurological diseases and can serve as biomarkers for these diseases. However, the information about circRNAs in Parkinson disease (PD) remained limited. In this study, we aimed to determine ...

Depression and Anxiety Management in Parkinson Disease.
https://doi.org/10.1097/JNN.0000000000000596
The Journal of Neuroscience Nursing : Journal of the Amer... Ho H, Jose I et. al.

Jun 11th, 2021 - BACKGROUND: Depression and anxiety are common but underrecognized and undertreated nonmotor symptoms of Parkinson disease (PD) due to their diagnostic criteria overlapping with other PD symptoms, limited randomized controlled studies in this speci...

Effectiveness and safety of moxibustion for Parkinson disease: A protocol for systemati...
https://doi.org/10.1097/MD.0000000000026256
Medicine Hou Y, Ning B et. al.

Jun 11th, 2021 - Parkinson disease (PD) is a common neurodegenerative disease among middle-aged and elderly people. Clinically, it is a movement disorder characterized mainly by static tremors, kinesia, myotonia, and postural balance disorder. In recent years, an ...

Retinal Microvascular and Choroidal Changes in Parkinson Disease.
https://doi.org/10.1001/jamaophthalmol.2021.1728
JAMA Ophthalmology; Ahn J, Shin JY et. al.

Jun 10th, 2021 - Retinal Microvascular and Choroidal Changes in Parkinson Disease.|2021|Ahn J,Shin JY,Lee JY,|

see more →

Guidelines  155 results

Gocovri Clinical Data
https://www.gocovrihcp.com/clinical-data/
Gocovrihcp.com

May 27th, 2020 - The efficacy and safety of GOCOVRI® 274 mg were evaluated in two Phase 3, randomized, placebo-controlled trials

Pain and dyskinesia in Parkinson's disease may share common pathophysiological mechanisms – An fMRI study
https://www.jns-journal.com/article/S0022-510X(20)30242-2/pdf
Journal of Neurological Sciences;

May 26th, 2020 - Parkinson's disease (PD) patients develop levodopa induced dyskinesia with disease progression from sensitization of central pathways. Pain pathways are also impacted with suggestions dyskinetic patients may process pain differently.

White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.50991
Annals of Clinical and Translational Neurology;

Feb 6th, 2020 - To investigate whether the burden of white matter hyperintensities (WMHs) is associated with the risk of developing levodopa‐induced dyskinesia (LID) in Parkinson’s disease (PD).

Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients
https://www.frontiersin.org/articles/10.3389/fneur.2019.01217/full
Frontiers in Neurology;

Nov 20th, 2019 - The forefront treatment of Parkinson's disease (PD) is Levodopa. When patients are treated with Levodopa cerebral blood flow is increased while cerebral metabolic rate is decreased in key subcortical regions including the putamen. This phenomenon ...

Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials
https://content.iospress.com/articles/journal-of-parkinsons-disease/jpd181565
Journal of Parkinson's Disease;

Jul 29th, 2019 - Evaluate prevalence of troublesome dyskinesia and OFF through the day, assessed by 30-minute intervals, as well as the mean number and duration of troublesome dyskinesia and OFF episodes, transitions between PD states, and effects of Gocovri® (ama...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  10,353 results

Should we start integrating genetic data in decision-making on device-aided therapies i...
https://doi.org/10.1016/j.parkreldis.2021.05.013
Parkinsonism & Related Disorders; Salles PA, Mata IF et. al.

Jun 13th, 2021 - Parkinson disease (PD) is a complex heterogeneous neurodegenerative disorder. Association studies have revealed numerous genetic risk loci and variants, and about 5-10% suffer from a monogenic form. Because the presentation and course of PD is uni...

RNA-sequencing of peripheral blood circular RNAs in Parkinson disease.
https://doi.org/10.1097/MD.0000000000025888
Medicine Kong F, Lv Z et. al.

Jun 11th, 2021 - Circular RNAs (circRNAs) play an important role in many neurological diseases and can serve as biomarkers for these diseases. However, the information about circRNAs in Parkinson disease (PD) remained limited. In this study, we aimed to determine ...

Depression and Anxiety Management in Parkinson Disease.
https://doi.org/10.1097/JNN.0000000000000596
The Journal of Neuroscience Nursing : Journal of the Amer... Ho H, Jose I et. al.

Jun 11th, 2021 - BACKGROUND: Depression and anxiety are common but underrecognized and undertreated nonmotor symptoms of Parkinson disease (PD) due to their diagnostic criteria overlapping with other PD symptoms, limited randomized controlled studies in this speci...

Effectiveness and safety of moxibustion for Parkinson disease: A protocol for systemati...
https://doi.org/10.1097/MD.0000000000026256
Medicine Hou Y, Ning B et. al.

Jun 11th, 2021 - Parkinson disease (PD) is a common neurodegenerative disease among middle-aged and elderly people. Clinically, it is a movement disorder characterized mainly by static tremors, kinesia, myotonia, and postural balance disorder. In recent years, an ...

Retinal Microvascular and Choroidal Changes in Parkinson Disease.
https://doi.org/10.1001/jamaophthalmol.2021.1728
JAMA Ophthalmology; Ahn J, Shin JY et. al.

Jun 10th, 2021 - Retinal Microvascular and Choroidal Changes in Parkinson Disease.|2021|Ahn J,Shin JY,Lee JY,|

see more →

News  465 results

A Breakthrough in Parkinson Disease and New Data on Treating Stroke
https://www.medscape.com/viewarticle/933212

Jul 12th, 2020 - This transcript has been edited for clarity. Dear colleagues, I'm Christoph Diener, a neurologist from the University of Duisburg-Essen in Germany, presenting six very interesting publications from February 2020 in the fields of stroke, multiple s...

The Gut a New Therapeutic Target for Brain Disorders?
https://www.staging.medscape.com/viewarticle/931719

Jun 3rd, 2020 - Changes in the mucus that lines the gastrointestinal (GI) tract may contribute to bacterial imbalance in the gut and exacerbate core symptoms of autism, Parkinson disease (PD), Alzheimer disease (AD), and multiple sclerosis (MS), new research sugg...

The Gut a New Therapeutic Target for Brain Disorders?
https://www.medscape.com/viewarticle/931719

Jun 3rd, 2020 - Changes in the mucus that lines the gastrointestinal (GI) tract may contribute to bacterial imbalance in the gut and exacerbate core symptoms of autism, Parkinson disease (PD), Alzheimer disease (AD), and multiple sclerosis (MS), new research sugg...

Gocovri Clinical Data
https://www.gocovrihcp.com/clinical-data/
Gocovrihcp.com

May 27th, 2020 - The efficacy and safety of GOCOVRI® 274 mg were evaluated in two Phase 3, randomized, placebo-controlled trials

Pain and dyskinesia in Parkinson's disease may share common pathophysiological mechanisms – An fMRI study
https://www.jns-journal.com/article/S0022-510X(20)30242-2/pdf
Journal of Neurological Sciences;

May 26th, 2020 - Parkinson's disease (PD) patients develop levodopa induced dyskinesia with disease progression from sensitization of central pathways. Pain pathways are also impacted with suggestions dyskinetic patients may process pain differently.

see more →

Patient Education  13 results see all →